Browsing Tag
Cleveland Clinic
12 posts
4DMedical (ASX: 4DX) stock up 7.3% as Mayo Clinic adoption and GSK contract reset lung imaging story
Nuclear medicine VQ scans are a US$1 billion market. 4DMedical (ASX: 4DX) just landed Mayo Clinic, GSK, and Medicare. The question is now scan volume scaling speed.
Arvind Krishna makes the case that AI complexity is IBM’s opportunity: Q1 2026 strategy in full
IBM CEO Arvind Krishna's Q1 2026 vision: AI governance, data sovereignty, mainframe acceleration, and the Confluent bet explained. Read IBM's full strategic case here.
Kardigan’s tonlamarsen data put acute severe hypertension into sharper commercial focus
Kardigan’s tonlamarsen Phase 2 data showed blood pressure promise despite mixed endpoints. Read what it means for acute severe hypertension next.
4DMedical (ASX: 4DX) secures CE Mark for CT:VQ and raises A$83m to accelerate European commercial launch
4DMedical (ASX: 4DX) secures CE Mark for CT:VQ and raises A$83M to fund EU expansion. Read what this means for investors and the respiratory imaging sector.
IBM introduces quantum-centric supercomputing architecture to integrate quantum processors with classical HPC systems
IBM unveils a quantum-centric supercomputing architecture integrating quantum processors with classical HPC systems. Discover what it means for science and industry.
4DMedical raises (ASX:4DX) $150m to fuel U.S. lung imaging push and expand AI respiratory portfolio
4DMedical raises $150M to scale CT:VQ in the U.S. with minimal dilution. Find out how this move sets the stage for profitability and market leadership.
Anixa Biosciences (NASDAQ: ANIX) moves forward as Phase 1 breast cancer vaccine data clear safety and immune hurdles
Anixa Biosciences’ breast cancer vaccine met Phase 1 safety and immune response targets. Find out how Keytruda combinations could transform care.
Method AI secures $20mn to build AI-powered surgical navigation platform for oncology procedures
Method AI raised $20mn to advance AI-powered surgical navigation, aiming to improve cancer surgery outcomes and reduce healthcare costs.
Former MADD CEO Debbie Weir joins Cancer Vaccine Coalition to accelerate therapeutic cancer vaccine movement
Debbie Weir, former MADD CEO, joins Cancer Vaccine Coalition to accelerate clinical trials and advocacy for therapeutic cancer vaccines in the U.S.
FDA approves Cerapedics’ PearlMatrix as first proven bone growth accelerator for lumbar spinal fusion
FDA approves Cerapedics' PearlMatrix™ bone graft for lumbar fusion; ASPIRE study confirms faster spinal healing in high-risk patients.